首页> 外文期刊>Journal of Clinical Microbiology >The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
【24h】

The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland

机译:十价肺炎球菌不可分型的流感嗜血嗜血杆菌蛋白D结合疫苗对 H。冰岛健康携带者和中耳感染中的流感

获取原文
       

摘要

Vaccinations with the 10-valent pneumococcal conjugated vaccine (PHiD-CV) started in Iceland in 2011. Protein D (PD) from H. influenzae , which is coded for by the hpd gene, is used as a conjugate in the vaccine and may provide protection against PD-positive H. influenzae . ABSTRACT Vaccinations with the 10-valent pneumococcal conjugated vaccine (PHiD-CV) started in Iceland in 2011. Protein D (PD) from H. influenzae , which is coded for by the hpd gene, is used as a conjugate in the vaccine and may provide protection against PD-positive H. influenzae . We aimed to evaluate the effect of PHiD-CV vaccination on H. influenzae in children, both in carriage and in acute otitis media (AOM). H. influenzae was isolated from nasopharyngeal swabs collected from healthy children attending 15 day care centers in 2009 and from 2012 to 2017 and from middle ear (ME) samples from children with AOM collected from 2012 to 2017. All isolates were identified using PCR for the hpd and fucK genes. Of the 3,600 samples collected from healthy children, 2,465 were culture positive for H. influenzae (68.5% carriage rate); of these, 151 (6.1%) contained hpd -negative isolates. Of the 2,847 ME samples collected, 889 (31.2%) were culture positive for H. influenzae ; of these, 71 (8.0%) were hpd negative. Despite the same practice throughout the study, the annual number of ME samples reduced from 660 in 2012 to 330 in 2017. The proportions of hpd -negative isolates in unvaccinated versus vaccinated children were 5.6% and 7.0%, respectively, in healthy carriers, and 5.4% and 7.8%, respectively, in ME samples. The proportion of hpd -negative isolates increased with time in ME samples but not in healthy carriers. The number of ME samples from children with AOM decreased. The PHiD-CV had no effect on the proportion of the hpd gene in H. influenzae from carriage, but there was an increase in hpd -negative H. influenzae in otitis media. The proportions of hpd -negative isolates remained similar in vaccinated and unvaccinated children.
机译:10价肺炎球菌结合疫苗(PHiD-CV)的疫苗接种于2011年在冰岛开始。hpd基因编码的流感嗜血杆菌蛋白质D(PD)被用作疫苗中的结合物,可能提供对PD阳性流感嗜血杆菌的保护。摘要10价肺炎球菌结合疫苗(PHiD-CV)的疫苗于2011年在冰岛开始接种。来自流感嗜血杆菌的蛋白质D(PD)由hpd基因编码,被用作疫苗中的结合物,可能提供针对PD阳性流感嗜血杆菌的保护。我们旨在评估PHiD-CV疫苗接种对儿童在运输中和在急性中耳炎(AOM)中的流感嗜血杆菌的影响。流感嗜血杆菌是从2009年和2012年至2017年在15个日托中心就诊的健康儿童的鼻咽拭子和2012年至2017年收集的AOM儿童的中耳(ME)样本中分离出来的。 hpd和fucK基因。在从健康儿童那里收集的3,600个样本中,有2,465个为流感嗜血杆菌培养阳性(运输率为68.5%);其中有151(6.1%)含有hpd阴性分离株。在收集的2847个ME样品中,有889个(31.2%)培养的流感嗜血杆菌阳性;其中71例(8.0%)为hpd阴性。尽管在整个研究中都采取了相同的做法,但每年的ME样本数量从2012年的660例减少到2017年的330例。健康携带者和未接种者中未接种疫苗的儿童与未接种疫苗的儿童中hpd阴性分离株的比例分别为5.6%和7.0%。 ME样品分别为5.4%和7.8%。在ME样品中,hpd阴性分离株的比例随时间增加,但在健康携带者中却没有。 AOM患儿的ME样品数量减少。 PHiD-CV对运输后流感嗜血杆菌中hpd基因的比例没有影响,但是在中耳炎中hpd阴性流感嗜血杆菌的含量增加。在接种疫苗和未接种疫苗的儿童中,hpd阴性分离株的比例仍然相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号